Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
WEBINAR ENDED
· 30 minutes

Understanding New Changes to the OVA1 Results Report (West Coast)

Thursday, November 3, 2016 · 12:30 p.m. · Pacific Time (US & Canada)
About This Webinar

In an interactive webinar, our team will walk you through how to integrate the OVA1 score with ultrasound result for a better assessment of ovarian cancer risk when managing adnexal masses.

Categories:
HEALTH & WELLNESS
Who can view: Everyone
Webinar Price: Free
Webinar ID: 69f6cab86349
Featured Presenters
Webinar hosting presenter ASPiRA L
ASPiRA Labs, a Vermillion Company
ASPiRA Labs is a wholly-owned, specialized women’s health reference laboratory of Vermillion, Inc. Its vision is to be the global leader in personalized medical management of gynecologic health to improve clinical outcomes for patients, physicians and payers. We pride ourselves on being at the forefront of women’s healthcare and ovarian cancer diagnosis.
Webinar hosting presenter Dr. M
Clinical Consultant at ASPiRA Labs
Webinar hosting presenter Dr. H
Lab Director of ASPiRA Labs
Hosted By
ASPiRA Labs, a Vermillion Company webinar platform hosts Understanding New Changes to the OVA1 Results Report (West Coast)
ASPiRA Labs, a Vermillion Company, presents "PATHWAYS" a webinar series to educate providers and women about our products to improve ovarian cancer detection.
Recommended